About this trial
People with end-stage kidney disease who receive hemodialysis are often told to strictly limit foods high in potassium, such as fruits, vegetables, legumes, nuts, and whole grains. This advice is intended to prevent high blood potassium levels (hyperkalemia), which can cause dangerous heart rhythm problems. However, these restrictions can make eating difficult, reduce diet quality, and lower quality of life. New research suggests that not all sources of potassium affect the body in the same way. Potassium added to highly processed foods is more easily absorbed than potassium naturally found in whole foods like fruits and vegetables. Large studies have found little evidence that eating potassium-rich whole foods increases blood potassium levels in people on dialysis. Clinical guidelines are beginning to shift, but no high-quality clinical trial has tested whether a more flexible, food-based approach is safe for people receiving hemodialysis. This study will compare two dietary approaches in 148 adults on hemodialysis: the usual low potassium diet and a "liberalized" potassium diet that encourages minimally processed foods while limiting highly processed foods with potassium additives. Participants will receive dietitian support and grocery assistance for 12 weeks. The investigators will closely monitor blood potassium levels to ensure safety. The investigators will also examine whether the liberalized diet is as safe as standard care, and whether it improves diet quality and quality of life. The investigators will also study factors that influence the participant's ability to follow the diet in real-world settings. If safe, this approach could reduce unnecessary food restrictions, improve diet quality, and enhance quality of life for people receiving hemodialysis, while maintaining patient safety.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years on maintenance HD >3 months
≥1 serum potassium concentration >5.0 mmol/L on routine bloodwork in past 12 months
Able to provide consent
Disqualifiers
Treatment with potassium binders within the preceding 7 days
Average Urea reduction rate over the past 3 months <65%
>2 missed scheduled dialysis sessions in the previous month
Patients receiving <3 hemodialysis sessions per week (ex/ incremental dialysis)
Trial design
Parallel
Treatments tested in this trial
Liberalized Potassium Diet
BehavioralFor 12 weeks, the liberalized potassium diet group (n=74) will increase their intake of minimally processed foods that are higher in potassium, including fruits, vegetables, nuts, legumes and whole grains, while limiting highly processed foods rich in potassium (\>200 mg/serving) and potassium additives. The liberalized diet will provide \~2600-3000. Participants will also be counselled to use cooking techniques to reduce potassium in root vegetables. The liberalized diet will provide \~2600-3000 mg potassium daily, reflecting the mean potassium intake of Canadian adults. Participants will receive weekly individualized counselling (30-60 min) during the first 4 weeks, followed by sessions (weeks 8 \& 12), reflecting usual care and to reinforce adherence. During weeks 1 to 4, weekly home deliveries of groceries will be provided to support early dietary adoption and adherence. During weeks 5-12, participants will receive weekly grocery gift cards to reduce financial barriers and support.
Low Potassium Diet
BehavioralThe control group (n= 74) will limit higher potassium fruits, vegetables, juices, and grains, to achieve a potassium intake of \~2000 mg/day. Participants will also be counselled to use cooking techniques (e.g., double-boiling root vegetables) to reduce potassium. Consistent with standard of care, participants will receive monthly education by a registered dietitian using standardized low potassium education materials that contain lists of foods to 'choose' and 'avoid', and individualized to ensure budget, cooking abilities and patient preferences are addressed, as needed. Participants will receive weekly grocery gift cards for 12 weeks.
Treatment groups
Trial outcomes
Primary outcomes
Time-averaged serum potassium
Time-averaged serum potassium is calculated as the mean of all weekly serum potassium measurements (mmol/L) for a participant over the defined study period, providing an integrated measure of potassium exposure over time and reducing the influence of isolated or transient fluctuations. Time-averaged serum potassium will be calculated as the area under the serum potassium-time curve divided by the total observation time.
Secondary outcomes
Safety - Severe Hyperkalemia
Incidence of clinically meaningful, severe hyperkalemia defined as incident non-hemolyzed serum potassium \>6.5 mmol/L at any time point during the study.
Dietary Nutrient Intake
Dietary intake will be assessed using the Automated Self-Administered 24-Hour Dietary Recall (ASA24-Canada-2018). The ASA24-C is a self-administered, web-based recall available in English and French (\~25 minutes) that incorporates Canadian foods and the Canadian Nutrient File for nutrient analysis. From the ASA24-C, we will calculate mean nutrient intakes, including potassium (mg/day).
Health-Related Quality of Life
Health-related quality of life will be assessed using the EQ-5D-5L, a validated, widely used generic indicator of overall health status. It is comprised of five questions assessing the dimension of mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Diet Quality
From the ASA24-C, diet quality will be assessed using the Healthy Eating Food Index-2019 (HEFI-2019) score (0-80).
Other outcomes
Barriers and Facilitators to Adoption of Dietary Intervention
In both study groups, to compare the barriers and facilitators that impact behaviour change and real-world implementation of the dietary interventions, at baseline and after the dietary intervention, using a validated questionaire
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Ontario Institute of Technology
Lead sponsor
Unity Health Toronto
Collaborator
This trial is not recruiting at the moment. You can still explore other options: